Testing effectiveness (Phase 2)Ended earlyNCT05327816
What this trial is testing
Various Respiratory Syncytial Virus (RSV) Pre-Fusion (preF)-Based Vaccine Formulations in Adults Aged 60 Years and Older
Who this might be right for
Respiratory Syncytial Virus-associated Lower Respiratory Tract Disease Prevention
Janssen Vaccines & Prevention B.V. 132